Recent Finacing
Recent Raise
Deciphera is a clinical-stage biopharmaceutical company developing switch-control small-molecule kinase inhibitors that lock kinases inactive to address tumor drug resistance across tumor-targeted and immuno-targeted programs (e.g., DCC-2618, DCC-3014).
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors